Summary: Several hereditary disorders, particularly those af-fecting the physiological anticoagulation systems, have been well established as risk factors for venous thromboembolism. In the present study, we investigated the prevalence of the following thrombogenic mutations in a Greek-Cypriot popula-tion: the G1691 factor V Leiden mutation, the G20210A mu-tation in the prothrombin gene, and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR). All three vari-ants have been documented to be significant risk factors for various cardiovascular conditions. Ninety unrelated subjects were screened. For the Leiden mutation, 11 subjects (12.2%) were heterozygous and one (1.1%) was homozygous. Seven subjects (7.8%) were heterozygou...
Objective: The present study was designed to determine the prevalence of factor V Leiden (FVL), prot...
Several inherited polymorphisms are associated with risk of venous thrombosis, including Mutation at...
The involvement in venous thrombosis of the two most common mutations of the hereditary haemochromat...
Background. This study was performed to establish the allele, genotype and genotype combination/SNP ...
Inherited thrombophilia is a genetically deter-mined tendency to venous thrombosis that de-velops in...
Different risk factors for venous thromboembolism (VTE) have been identified, including hereditary a...
Background: Inherited thrombophilia may be caused by mutations, polymorphisms in a variety of genes ...
Background. Polymorphisms of factor V (Leiden) (G1691A) and the gene for prothrombin (G20210A) are t...
Background: Thromboembolic disease (TED) represents one of the main reasons of morbitity and mortali...
A difference in the prevalence of venous thromboembolism (TE) in major human groups has been describ...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Inherited resistance to activated protein C caused by the factor V Leiden (FVL) mutation is the most...
Background: The factor V Leiden mutation is a genetic defect associated with an increased incidence ...
Prothrombin variant 20210A is maintained to be a mild risk factor for venous thromboembolism (VTE). ...
Objective: The present study was designed to determine the prevalence of factor V Leiden (FVL), prot...
Several inherited polymorphisms are associated with risk of venous thrombosis, including Mutation at...
The involvement in venous thrombosis of the two most common mutations of the hereditary haemochromat...
Background. This study was performed to establish the allele, genotype and genotype combination/SNP ...
Inherited thrombophilia is a genetically deter-mined tendency to venous thrombosis that de-velops in...
Different risk factors for venous thromboembolism (VTE) have been identified, including hereditary a...
Background: Inherited thrombophilia may be caused by mutations, polymorphisms in a variety of genes ...
Background. Polymorphisms of factor V (Leiden) (G1691A) and the gene for prothrombin (G20210A) are t...
Background: Thromboembolic disease (TED) represents one of the main reasons of morbitity and mortali...
A difference in the prevalence of venous thromboembolism (TE) in major human groups has been describ...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Inherited resistance to activated protein C caused by the factor V Leiden (FVL) mutation is the most...
Background: The factor V Leiden mutation is a genetic defect associated with an increased incidence ...
Prothrombin variant 20210A is maintained to be a mild risk factor for venous thromboembolism (VTE). ...
Objective: The present study was designed to determine the prevalence of factor V Leiden (FVL), prot...
Several inherited polymorphisms are associated with risk of venous thrombosis, including Mutation at...
The involvement in venous thrombosis of the two most common mutations of the hereditary haemochromat...